loading

Syndax Pharmaceuticals Inc Stock (SNDX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
2.07%
79.51
77.91 56.35 49.68 46.02
Interest Income/Expense
12.70%
0.055
0.063 0.07 0.035 0.04
Operating Income/Loss
2.07%
-79.51
-77.91 -56.35 -49.68 -46.02
Nonoperating Income/Loss
30.96%
7.114
5.432 5.209 5.063 4.889
Income/Loss From Continuing Operations Before Tax
0.10%
-72.40
-72.47 -51.15 -44.62 -41.13
Income/Loss From Continuing Operations After Tax
0.10%
-72.40
-72.47 -51.15 -44.62 -41.13
Net Income/Loss
0.10%
-72.40
-72.47 -51.15 -44.62 -41.13
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
11,660%
85.21
0.7246 69.86 69.64 69.44
Diluted Average Shares
11,660%
85.21
0.7246 69.86 69.64 69.44
Basic Earnings Per Share
15.84%
-0.85
-1.01 -0.73 -0.64 -0.59
Diluted Earnings Per Share
15.84%
-0.85
-1.01 -0.73 -0.64 -0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):